Biopharmaceutical manufacturer.
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," including policy and implementation issues.
Public Law No. 110-85, the "Food and Drug Administration Amendments Act," including current policy issues relating to FDA's Risk Evaluation and Mitigation Strategy authority.
H.R. 5657, the "Fair Access for Safe and Timely Generics Act."
H.R. 3230, the "Veterans' Access to Care through Choice, Accountability and Transparency Act."
H.R. 3116, the "Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act."
Policy issues relating to orphan drugs and medicines for rare diseases. H.R. 3230, the "Veterans' Access to Care through Choice, Accountability and Transparency Act."
HCR - Health Issues VET - Veterans
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FERGUSON STRATEGIES, LLC
801 Pennsylvania Ave NW, Suite 230, Washington, DC, 20004-2697, US
CHRIS JONES ADAM HIGGINS CHRIS JONES ADAM HIGGINS